|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
04-25-2010, 03:46 AM
|
|||
|
|||
Moffitt Cancer Center Announces Growing Interest In Recently Launched Prognostic Test
Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer. The ERCC1 Analysis measures ERCC1 levels in cells to predict response to cisplatin-based chemotherapy. The correlation between ERCC1 levels and therapy ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Running notebook: Participation, interest keep growing | cancerfr | Neuroblastoma | 0 | 08-13-2010 03:59 AM |
| Moffitt Cancer Center: Growing interest in prognostic test for non-small cell lung ca | cancerfr | Lung Cancer | 0 | 04-26-2010 11:14 PM |
| Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selectin | cancerfr | Bone Cancer | 0 | 04-25-2010 03:46 AM |
Linear Mode
